MX377166B - Activacion de las plaquetas y liberacion del factor de crecimiento utilizando pulsos electricos. - Google Patents

Activacion de las plaquetas y liberacion del factor de crecimiento utilizando pulsos electricos.

Info

Publication number
MX377166B
MX377166B MX2016009316A MX2016009316A MX377166B MX 377166 B MX377166 B MX 377166B MX 2016009316 A MX2016009316 A MX 2016009316A MX 2016009316 A MX2016009316 A MX 2016009316A MX 377166 B MX377166 B MX 377166B
Authority
MX
Mexico
Prior art keywords
growth factor
electrical pulses
platelet activation
factor release
release
Prior art date
Application number
MX2016009316A
Other languages
English (en)
Other versions
MX2016009316A (es
Inventor
Allen Lawrence Garner
Andrew Soliz Torres
Antonio Caiafa
Brian Duh- Lan LEE
Vasile Bogdan Neculaes
Original Assignee
Gen Electric
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Electric filed Critical Gen Electric
Publication of MX2016009316A publication Critical patent/MX2016009316A/es
Publication of MX377166B publication Critical patent/MX377166B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
    • C12Y306/01—Hydrolases acting on acid anhydrides (3.6) in phosphorus-containing anhydrides (3.6.1)
    • C12Y306/01005—Apyrase (3.6.1.5), i.e. ATP diphosphohydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Ecology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

La presente invención se refiere a métodos y sistemas para la liberación de factores de crecimiento; en ciertas modalidades, una muestra de sangre se expone a una secuencia de uno o más pulsos eléctricos para desencadenar la liberación de un factor de crecimiento en la muestra; en ciertas modalidades, la liberación del factor de crecimiento no está acompañada de coagulación dentro de la muestra de sangre.
MX2016009316A 2014-01-17 2015-01-09 Activacion de las plaquetas y liberacion del factor de crecimiento utilizando pulsos electricos. MX377166B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/157,819 US9452199B2 (en) 2014-01-17 2014-01-17 Platelet activation and growth factor release using electric pulses
PCT/US2015/010817 WO2015108778A1 (en) 2014-01-17 2015-01-09 Platelet activation and growth factor release using electric pulses

Publications (2)

Publication Number Publication Date
MX2016009316A MX2016009316A (es) 2016-10-13
MX377166B true MX377166B (es) 2025-03-07

Family

ID=52424133

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016009316A MX377166B (es) 2014-01-17 2015-01-09 Activacion de las plaquetas y liberacion del factor de crecimiento utilizando pulsos electricos.

Country Status (12)

Country Link
US (5) US9452199B2 (es)
EP (2) EP3094970B1 (es)
JP (1) JP6625542B2 (es)
KR (1) KR102277931B1 (es)
CN (1) CN105899949B (es)
AU (2) AU2015206756B2 (es)
CA (1) CA2936230C (es)
ES (1) ES2929394T3 (es)
MX (1) MX377166B (es)
RU (1) RU2712234C2 (es)
TW (1) TWI673054B (es)
WO (1) WO2015108778A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9708597B2 (en) * 2014-01-17 2017-07-18 General Electric Company Electric pulse generation systems using capacitive coupling
US9452199B2 (en) * 2014-01-17 2016-09-27 General Electric Company Platelet activation and growth factor release using electric pulses
US9752120B2 (en) 2015-03-31 2017-09-05 General Electric Company Activated platelet composition with tunable growth factor level
US10633645B2 (en) * 2015-12-30 2020-04-28 General Electric Company Calcium controlled activation of platelets via electrical stimulation
WO2017176253A1 (en) * 2016-04-05 2017-10-12 General Electiric Comapny Activated platelet composition with tunable growth factor level
US10968423B2 (en) 2018-02-26 2021-04-06 General Electric Company System and method for electric pulse based activation of biological samples
US20200000709A1 (en) * 2018-06-29 2020-01-02 Cal-X Stars Business Accelerator, Inc. Combination of bioelectrical stimulator and platelet-rich fibrin for accelerated healing and regeneration
WO2020146702A2 (en) * 2019-01-10 2020-07-16 Nanovis, Inc. Methods for stimulating the proliferation and differentiation of eukaryotic cells
JP7248721B2 (ja) * 2021-02-17 2023-03-29 ゼネラル・エレクトリック・カンパニイ 成長因子レベルを調節可能な活性化血小板組成物
WO2026018855A1 (ja) * 2024-07-18 2026-01-22 株式会社AdipoSeeds 血小板の機能を評価する方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor
US7053063B2 (en) 1999-07-21 2006-05-30 The Regents Of The University Of California Controlled electroporation and mass transfer across cell membranes in tissue
WO2001007070A1 (en) * 1999-07-23 2001-02-01 The Scripps Research Institute Method for measuring coagulant factor activity in whole blood
US6326177B1 (en) 1999-08-04 2001-12-04 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Method and apparatus for intracellular electro-manipulation
DE10119901A1 (de) * 2001-04-23 2002-10-24 Amaxa Gmbh Schaltungsanordnung zur Einbringung von Nukleinsäuren und anderen biologisch aktiven Molekülen in den Kern höherer eukaryontischer Zellen mit Hilfe elektrischen Stroms
EP1648555B1 (en) * 2003-07-18 2015-09-02 Eastern Virginia Medical School Method for introducing an Agent into a Cell
US6897069B1 (en) 2004-06-08 2005-05-24 Ambion, Inc. System and method for electroporating a sample
US7565201B2 (en) 2004-12-17 2009-07-21 Eastern Virginia Medical School Activation of calcium-mediated cell functions in cells and tissues, including aggregation of human platelets. by nanosecond pulsed electric fields
US7923238B2 (en) * 2006-02-10 2011-04-12 Bio-Rad Laboratories, Inc. Multi-channel electroporation system
US7750605B2 (en) 2006-09-21 2010-07-06 Bio-Rad Laboratories, Inc. Controlling an electrical signal sent to a sample load using a pulse modulated resistance
US8222909B2 (en) 2008-08-22 2012-07-17 Bio-Rad Laboratories, Inc. Electroporation system with dial-in time constant
CA2743841C (en) * 2008-11-13 2020-09-01 Eastern Virginia Medical School Activation and aggregation of human platelets and formation of platelet gels by nanosecond pulsed electric fields
EP2406007A4 (en) * 2009-03-10 2013-03-06 Univ Monash THROMBOZYTE AGGREGATION ON THE BASIS OF A MICROFLUIDIC DEVICE
EP2419175A1 (en) * 2009-04-15 2012-02-22 Koninklijke Philips Electronics N.V. Tumor treatment using ultrasound cavitation
KR101114712B1 (ko) * 2009-10-23 2012-02-29 세원셀론텍(주) 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(ｐｒｐ)을 활성화하여 조직재생을 유도하는 조성물의 제조방법
AU2010330861B2 (en) * 2009-12-18 2013-09-26 Entegrion, Inc. Portable coagulation monitoring device and method of assessing coagulation response
US8535662B2 (en) * 2010-01-13 2013-09-17 Apt Therapeutics, Inc. Apyrase therapy for bleeding conditions
US9164079B2 (en) * 2011-03-17 2015-10-20 Greyledge Technologies Llc Systems for autologous biological therapeutics
US9078862B2 (en) * 2013-06-06 2015-07-14 General Electric Company Platelet activation using long electric field pulses
US9452199B2 (en) * 2014-01-17 2016-09-27 General Electric Company Platelet activation and growth factor release using electric pulses

Also Published As

Publication number Publication date
RU2712234C2 (ru) 2020-01-27
RU2016126427A (ru) 2018-02-20
EP3094970A1 (en) 2016-11-23
CA2936230C (en) 2022-06-14
CA2936230A1 (en) 2015-07-23
US10369200B2 (en) 2019-08-06
US20150202264A1 (en) 2015-07-23
MX2016009316A (es) 2016-10-13
EP3502690B1 (en) 2022-09-07
AU2015206756B2 (en) 2020-05-14
US10383915B2 (en) 2019-08-20
EP3094970B1 (en) 2019-03-06
US20190336578A1 (en) 2019-11-07
WO2015108778A1 (en) 2015-07-23
US20160367632A1 (en) 2016-12-22
US11464829B2 (en) 2022-10-11
US12042526B2 (en) 2024-07-23
KR102277931B1 (ko) 2021-07-15
KR20160108419A (ko) 2016-09-19
TWI673054B (zh) 2019-10-01
JP2017505608A (ja) 2017-02-23
EP3502690A1 (en) 2019-06-26
AU2020207831B2 (en) 2022-01-13
TW201620529A (zh) 2016-06-16
RU2016126427A3 (es) 2018-07-27
ES2929394T3 (es) 2022-11-28
US20160367633A1 (en) 2016-12-22
US20230013598A1 (en) 2023-01-19
US9452199B2 (en) 2016-09-27
CN105899949B (zh) 2019-09-03
AU2015206756A1 (en) 2016-07-21
JP6625542B2 (ja) 2019-12-25
CN105899949A (zh) 2016-08-24
AU2020207831A1 (en) 2020-08-13

Similar Documents

Publication Publication Date Title
MX2016009316A (es) Activacion de las plaquetas y liberacion del factor de crecimiento utilizando pulsos electricos.
DK3512861T3 (da) Cykliske dinukleotider som sting-(stimulator af interferongener)-agonister
IL258927B (en) Systems for thrombectomy
EP3430132C0 (en) GENERATION OF MIDBRRAIN-SPECIFIC ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS
EP3444295A4 (en) BIPOLAR MEMBRANE
CL2016003416A1 (es) Herbicidas de piperidinona
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
MX374788B (es) Anticuerpos anti-tim3 y metodos de uso.
CL2017003297A1 (es) Métodos de deshidratación de soluciones alcohólicas mediante osmosis y sistemas relacionados.
EP3311742A4 (en) BLOOD COLLECTORS
MX386587B (es) ANTICUERPOS ANTI-CD79b Y MÉTODOS DE USO.
MX2016014890A (es) Agonistas del receptor de apelina (apj) y usos de los mismos.
TWD177712S (zh) 置物架
DK3223829T3 (da) Behandling af sygdomme associeret med hepatisk stellat-celleaktivering under anvendelse af ammoniak-sænkende terapier
EP2989939A4 (en) CREATIVE, RELAXATION AND FLEXIBLE RESOURCES
EP4056208C0 (en) BLOOD PROCESSING SYSTEMS
UY36171A (es) Derivados heteroaromáticos bicíclicos fusionados como inhibidores de quinasa
MX2017011194A (es) Anticuerpos, usos y métodos.
EP3660186A4 (en) ELECTROCHEMICAL OXYGEN GENERATION APPARATUS
MY165760A (en) Absorbent article
CL2016003076A1 (es) Péptidos como agonistas de la oxitocina
BR112015016577A2 (pt) elemento de fixação e seringa
MX384126B (es) Artículo absorbente con adhesivo sin plastificantes.
IL250495B (en) Stem cell compositions and methods of producing stem cells for therapeutic applications
DK3189844T3 (da) Pluripotent stamcelle til behandling af diabetisk hudsår

Legal Events

Date Code Title Description
FG Grant or registration